IL-1 Blockade Attenuates Islet Amyloid Polypeptide-Induced Proinflammatory Cytokine Release and Pancreatic Islet Graft Dysfunction

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Immunology

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1002854PMID 21813778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome*

  2010cited by this paper
• Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

  2010cited by this paper
• Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts

  2010cited by this paper
• Cytokine production by islets in health and diabetes: cellular origin, regulation and function.

  2010cited by this paper
• Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity*

  2010cited by this paper
• CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

  2009cited by this paper
• Glyburide inhibits the Cryopyrin/Nalp3 inflammasome

  2009cited by this paper
• Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes

  2009cited by this paper
• Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2.

  2009cited by this paper
• Islet-associated macrophages in type 2 diabetes

  2009cited by this paper
• Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I.

  2009cited by this paper
• Amyloid inhibitors enhance survival of cultured human islets.

  2009cited by this paper
• Amyloid-beta(1-42) fibrillar precursors are optimal for inducing tumor necrosis factor-alpha production in the THP-1 human monocytic cell line.

  2009cited by this paper
• PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification

  2009cited by this paper
• Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

  2008cited by this paper
• Widespread amyloid deposition in transplanted human pancreatic islets.

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane

  2008cited by this paper
• Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.

  2008cited by this paper
• Small Interfering RNA–Mediated Suppression of Proislet Amyloid Polypeptide Expression Inhibits Islet Amyloid Formation and Enhances Survival of Human Islets in Culture

  2008cited by this paper
• Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets

  2008cited by this paper
• The NALP3 inflammasome is involved in the innate immune response to amyloid-β

  2008cited by this paper
• Critical Roles for Macrophages in Islet Angiogenesis and Maintenance During Pancreatic Degeneration

  2008cited by this paper
• Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

  2008cited by this paper
• Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112.

  2007cited by this paper
• Toll‐like receptors 2 and 4 mediate Aβ(1–42) activation of the innate immune response in a human monocytic cell line

  2007cited by this paper
• Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

  2007cited by this paper
• Increased Number of Islet-Associated Macrophages in Type 2 Diabetes

  2007cited by this paper
• Complement activation by islet amyloid polypeptide (IAPP) and α-synuclein 112

  2007cited by this paper
• An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets

  2006cited by this paper
• Role of toll-like receptor signalling in Abeta uptake and clearance.

  2006cited by this paper
• Mechanisms linking obesity to insulin resistance and type 2 diabetes

  2006cited by this paper
• IL-1 Receptor antagonist as a positional candidate gene in a murine model of allergic asthma

  2006cited by this paper
• Differing caspase‐1 activation states in monocyte versus macrophage models of IL‐1β processing and release

  2004cited by this paper
• Human Amylin Oligomer Growth and Fibril Elongation Define Two Distinct Phases in Amyloid Formation*

  2004cited by this paper
• Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid.

  2003cited by this paper
• Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

  2003cited by this paper
• Full-length rat amylin forms fibrils following substitution of single residues from human amylin.

  2003cited by this paper
• β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

  2003cited by this paper
• "In vivo" depletion of macrophages by liposome-mediated "suicide".

  2003cited by this paper
• Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function.

  2002cited by this paper
• Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

  2002cited by this paper
• Macrophages from High‐Risk HLA‐DQB1*0201/*0302 Type 1 Diabetes Mellitus Patients are Hypersensitive to Lipopolysaccharide Stimulation

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Identification of a Heparin Binding Domain in the N-terminal Cleavage Site of Pro-islet Amyloid Polypeptide

  2001cited by this paper
• Human Amylin Stimulates Inflammatory Cytokine Secretion from Human Glioma Cells

  2000cited by this paper
• Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP‐1 Cells and Murine Microglia

  2000cited by this paper
• Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

  1999cited by this paper
• The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

  1999cited by this paper
• Fibrillar islet amyloid polypeptide (amylin) is internalised by macrophages but resists proteolytic degradation

  1998cited by this paper
• A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation.

  1998cited by this paper
• Macrophages and pancreatic islet amyloidosis.

  1998cited by this paper
• Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

  1996cited by this paper
• Treatment With Growth Hormone and Dexamethasone in Mice Transgenic for Human Islet Amyloid Polypeptide Causes Islet Amyloidosis and β-Cell Dysfunction

  1996cited by this paper
• Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.

  1996cited by this paper
• Rapid deposition of amyloid in human islets transplanted into nude mice

  1995cited by this paper
• Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.

  1990cited by this paper
• Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells

  1990cited by this paper
• Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits.

  1990cited by this paper
• Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.

  1987cited by this paper

• O-glycosylated peptides curtail the aggregation and toxicity of human islet amyloid polypeptide

  2025cites this paper
• Heparan sulfate fine-tuned interleukin-1 (IL-1) signaling inhibits insulin secretion of grafted pancreatic islets

  2025cites this paper
• Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice

  2025cites this paper
• Islet amyloid disrupts MHC Class II antigen presentation and protects NOD mice from autoimmune diabetes

  2024cites this paper
• Targeting the NLRP3 inflammasome–IL-1β pathway in type 2 diabetes and obesity

  2024cites this paper
• Pathological evaluation of the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy

  2024cites this paper
• Role of the Pancreatic Islet Microvasculature in Health and Disease

  2024cites this paper
• Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models

  2024cites this paper
• Advancements in innate immune regulation strategies in islet transplantation

  2024cites this paper
• Understanding the structural dynamics of human islet amyloid polypeptide: Advancements in and applications of ion-mobility mass spectrometry.

  2024cites this paper
• Research advances in understanding crosstalk between organs and pancreatic β‐cell dysfunction

  2024cites this paper
• Pancreatic islet transplantation: current advances and challenges

  2024cites this paper
• Dépistage des anomalies de la tolérance au glucose et du diabète de mucoviscidose. Position de la Société française de la mucoviscidose (SFM), de la Société francophone du diabète (SFD) et de la Société française d’endocrinologie et diabétologie pédiatrique (SFEDP)

  2023cites this paper
• Protein aggregation: A detrimental symptom or an adaptation mechanism?

  2023cites this paper
• β-cell neogenesis: A rising star to rescue diabetes mellitus

  2023cites this paper
• Cross-seeding enables repurposing of aurein antimicrobial peptides as a promoter of human islet amyloid polypeptide (hIAPP).

  2023cites this paper
• Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

  2023cites this paper
• Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis.

  2023cites this paper
• Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes

  2023cites this paper
• Big versus small: The impact of aggregate size in disease

  2023cites this paper
• Calcium-dependent transcriptional profiles of human pancreatic islet cells reveal functional diversity in islet subpopulations

  2023cites this paper
• The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases

  2023cites this paper
• Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities

  2023cites this paper
• Ae1/Sbe1 maize-derived high amylose improves gut barrier function and ameliorates type II diabetes in high-fat diet-fed mice by increasing Akkermansia

  2022cites this paper
• Islet amyloid polypeptide aggregation exerts cytotoxic and proinflammatory effects on the islet vasculature in mice

  2022cites this paper
• Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes.

  2022cites this paper
• Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective

  2022cites this paper
• Calcium-dependent transcriptional changes in human pancreatic islet cells reveal functional diversity in islet cell subtypes

  2022cites this paper
• Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus

  2022cites this paper
• 4-Phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity

  2021cites this paper
• Neuroinflammation as a Common Denominator of Complex Diseases (Cancer, Diabetes Type 2, and Neuropsychiatric Disorders)

  2021cites this paper
• Amylin Dyshomeostasis Hypothesis: Small Vessel-Type Ischemic Stroke in the Setting of Type-2 Diabetes.

  2021cites this paper
• Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease

  2021cites this paper
• The β Cell in Diabetes: Integrating Biomarkers with Functional Measures.

  2021cites this paper
• Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates

  2021cites this paper
• Synthesis of Yakuchinone B-Inspired Inhibitors against Islet Amyloid Polypeptide Aggregation.

  2021cites this paper
• Polysaccharides and immune function

  2021cites this paper
• Dapagliflozin ameliorates pancreatic injury and activates kidney autophagy by modulating the AMPK/mTOR signaling pathway in obese rats

  2021cites this paper
• T cells accumulate in non-diabetic islets during ageing

  2021cites this paper
• Human islet amyloid polypeptide (hIAPP) - a curse in type II diabetes mellitus: insights from structure and toxicity studies.

  2021cites this paper
• Protein Kinases Signaling in Pancreatic Beta-cells Death and Type 2 Diabetes.

  2021cites this paper
• Differential cytokine expression in direct and indirect co-culture of islets and mesenchymal stromal cells.

  2021cites this paper
• Islet amyloid toxicity: From genesis to counteracting mechanisms

  2021cites this paper
• L’inflammation dans la physiopathologie et le traitement du diabète de type 2 et de ses complications

  2021cites this paper
• β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances

  2021cites this paper
• Human islet amyloid polypeptide (hIAPP) - a curse in type II diabetes mellitus: insights from structure and toxicity studies

  2020cites this paper
• Beta Cell Physiological Dynamics and Dysfunctional Transitions in Response to Islet Inflammation in Obesity and Diabetes

  2020cites this paper
• Toll-Like Receptor 4 and Inflammatory Micro-Environment of Pancreatic Islets in Type-2 Diabetes Mellitus: A Therapeutic Perspective

  2020cites this paper
• Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus

  2020cites this paper
• The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease.

  2020cites this paper
• PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes in mice

  2020cites this paper
• Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction

  2020cites this paper
• DMSO_A_279104 4261..4272

  2020cites this paper
• The Role of Interleukin-1β in Destruction of Transplanted Islets

  2020cites this paper
• T cells are present in non-diabetic islets and accumulate during aging

  2020cites this paper
• Good Cop, Bad Cop: The Opposing Effects of Macrophage Activation State on Maintaining or Damaging Functional β-Cell Mass

  2020cites this paper
• Islet macrophages drive islet vascular remodeling and compensatory hyperinsulinemia in the early stages of diabetes

  2019cites this paper
• RNA-seq-based identification of Star upregulation by islet amyloid formation.

  2019influential citation
• Fermentation Products of Paenibacillus bovis sp. nov. BD3526 Alleviates the Symptoms of Type 2 Diabetes Mellitus in GK Rats

  2019cites this paper
• Anti-Diabetic Effects and Mechanisms of Dietary Polysaccharides

  2019cites this paper
• Blocking inflammasome activation caused by β-amyloid peptide (Aβ) and islet amyloid polypeptide (IAPP) through an IAPP mimic.

  2019cites this paper
• Zebrafish models of diabetes-related CNS pathogenesis.

  2019cites this paper
• 3-D physiomimetic extracellular matrix hydrogels provide a supportive microenvironment for rodent and human islet culture.

  2019cites this paper
• Inflammation in the pathophysiology and therapy of cardiometabolic disease.

  2019cites this paper
• Use of anti-inflammatory agents in clinical islet cell transplants: A qualitative systematic analysis

  2019cites this paper
• Islet inflammation in type 2 diabetes

  2019cites this paper
• Effects of in vivo conditions on amyloid aggregation.

  2019cites this paper
• Modulation of Innate Immunity by Amyloidogenic Peptides.

  2019cites this paper
• Survival in a bad neighborhood: pancreatic islets in cystic fibrosis.

  2019cites this paper
• Endocrine Complications of Cystic Fibrosis: A Multisystem Disease of the Endocrine Organs

  2019cites this paper
• Targeting innate immune mediators in type 1 and type 2 diabetes

  2019cites this paper
• Human Islet Response to Selected Type 1 Diabetes-Associated Bacteria: A Transcriptome-Based Study

  2019cites this paper
• Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure

  2018cites this paper
• Regulation of the β-cell inflammasome and contribution to stress-induced cellular dysfunction and apoptosis.

  2018cites this paper
• The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies

  2018cites this paper
• Incretin Hormones and Insulin Responses During OGTT in Newly Diagnosed T2DM Patients

  2018influential citation
• RAGE binds preamyloid IAPP intermediates and mediates pancreatic &bgr; cell proteotoxicity

  2018cites this paper
• Linkage of Infection to Adverse Systemic Complications: Periodontal Disease, Toll-Like Receptors, and Other Pattern Recognition Systems

  2018cites this paper
• IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants.

  2018cites this paper
• No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases

  2018cites this paper
• Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide

  2017cites this paper
• Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?

  2017cites this paper
• The β-cell assassin: IAPP cytotoxicity.

  2017cites this paper
• Fasting levels of insulin and amylin after acute pancreatitis are associated with pro-inflammatory cytokines

  2017cites this paper
• Clinical Implications of Osmolytes in Various Human Diseases

  2017cites this paper
• Autophagic Dysfunction in Type 2 Diabetes Mellitus: Pathophysiology and Therapeutic Implications

  2017cites this paper
• Novel Fusion Protein Targeting Mitochondrial DNA Improves Pancreatic Islet Functional Potency and Islet Transplantation Outcomes

  2017cites this paper
• Amyloid‐induced β‐cell dysfunction and islet inflammation are ameliorated by 4‐phenylbutyrate (PBA) treatment

  2017cites this paper
• The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation

  2017cites this paper
• Interorgan Crosstalk Contributing to β-Cell Dysfunction

  2017cites this paper
• Anakinra Protects Against Serum Deprivation‐Induced Inflammation and Functional Derangement in Islets Isolated From Nonhuman Primates

  2017cites this paper
• Amylin and diabetic cardiomyopathy - amylin-induced sarcolemmal Ca2+ leak is independent of diabetic remodeling of myocardium.

  2017cites this paper
• IAPP modulates cellular autophagy, apoptosis, and extracellular matrix metabolism in human intervertebral disc cells

  2017cites this paper
• When beta cells talk back

  2017cites this paper
• Islet inflammation in type 2 diabetes and physiology

  2017cites this paper
• Inflammation and its Disease Consequences

  2017cites this paper
• BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression

  2017cites this paper
• Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes

  2017cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes.

  2016cites this paper
• Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes

  2016cites this paper